BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26355157)

  • 1. Requirement for Transcription Factor Ets1 in B Cell Tolerance to Self-Antigens.
    Russell L; John S; Cullen J; Luo W; Shlomchik MJ; Garrett-Sinha LA
    J Immunol; 2015 Oct; 195(8):3574-83. PubMed ID: 26355157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
    Luo W; Mayeux J; Gutierrez T; Russell L; Getahun A; Müller J; Tedder T; Parnes J; Rickert R; Nitschke L; Cambier J; Satterthwaite AB; Garrett-Sinha LA
    J Immunol; 2014 Jul; 193(2):909-920. PubMed ID: 24929000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
    Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
    J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.
    Chackerian B; Durfee MR; Schiller JT
    J Immunol; 2008 May; 180(9):5816-25. PubMed ID: 18424700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen.
    Taylor JJ; Martinez RJ; Titcombe PJ; Barsness LO; Thomas SR; Zhang N; Katzman SD; Jenkins MK; Mueller DL
    J Exp Med; 2012 Oct; 209(11):2065-77. PubMed ID: 23071255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.
    Akerlund J; Getahun A; Cambier JC
    J Autoimmun; 2015 Aug; 62():45-54. PubMed ID: 26152931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell receptor signaling-based index as a biomarker for the loss of peripheral immune tolerance in autoreactive B cells in rheumatoid arthritis.
    Lyubchenko T; Zerbe GO
    PLoS One; 2014; 9(7):e102128. PubMed ID: 25057856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory.
    Koenig-Marrony S; Soulas P; Julien S; Knapp AM; Garaud JC; Martin T; Pasquali JL
    J Immunol; 2001 Feb; 166(3):1463-70. PubMed ID: 11160185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology. B cell receptor rehabilitation--pausing to reflect.
    King LB; Monroe JG
    Science; 2001 Feb; 291(5508):1503-5. PubMed ID: 11234081
    [No Abstract]   [Full Text] [Related]  

  • 11. Ets1 Controls the Development of B Cell Autoimmune Responses in a Cell-Intrinsic Manner.
    Sunshine A; Goich D; Stith A; Sortino K; Dalton J; Metcalfe S; Svensson EC; Garrett-Sinha LA
    Immunohorizons; 2019 Jul; 3(7):331-340. PubMed ID: 31356162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5 maintains tolerance in anergic B cells.
    Hippen KL; Tze LE; Behrens TW
    J Exp Med; 2000 Mar; 191(5):883-90. PubMed ID: 10704468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactivity and the positive selection of B cells.
    Übelhart R; Jumaa H
    Eur J Immunol; 2015 Nov; 45(11):2971-7. PubMed ID: 26350303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease.
    Hannum LG; Ni D; Haberman AM; Weigert MG; Shlomchik MJ
    J Exp Med; 1996 Oct; 184(4):1269-78. PubMed ID: 8879198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.
    Morlacchi S; Soldani C; Viola A; Sarukhan A
    Blood; 2011 Jul; 118(4):984-91. PubMed ID: 21652680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antigen B cells that down-regulate surface B cell receptor during development to mature, follicular phenotype do not display features of anergy in vitro.
    Liu X; Manser T
    J Immunol; 2005 Apr; 174(8):4505-15. PubMed ID: 15814671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracing Self-Reactive B Cells in Normal Mice.
    Nojima T; Reynolds AE; Kitamura D; Kelsoe G; Kuraoka M
    J Immunol; 2020 Jul; 205(1):90-101. PubMed ID: 32414809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal redemption and clonal anergy as mechanisms to balance B cell tolerance and immunity.
    Burnett DL; Reed JH; Christ D; Goodnow CC
    Immunol Rev; 2019 Nov; 292(1):61-75. PubMed ID: 31556969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.
    Mayeux J; Skaug B; Luo W; Russell LM; John S; Saelee P; Abbasi H; Li QZ; Garrett-Sinha LA; Satterthwaite AB
    J Immunol; 2015 Sep; 195(5):1955-63. PubMed ID: 26209625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.